DaVita Inc. (DVA)
NYSE: DVA
· Real-Time Price · USD
136.19
-0.47 (-0.34%)
At close: May 29, 2025, 3:59 PM
135.99
-0.15%
After-hours: May 29, 2025, 07:58 PM EDT
DaVita Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U S Dialysis And Related Lab Services Revenue | 11.32B | 10.94B | 10.6B | 10.67B | 10.66B | 10.56B | 10.37B | 9.82B | 9.55B | 9.03B | 8.55B | 8.03B | 7.32B |
| U S Dialysis And Related Lab Services Revenue Growth | +3.49% | +3.18% | -0.63% | +0.07% | +0.92% | +1.89% | +5.55% | +2.84% | +5.73% | +5.66% | +6.44% | +9.79% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 374.09M | 414.48M | 393.53M | 367.85M | 362.48M | 401.47M | 376.88M | 364.02M | 331.61M | 379.71M | 365.45M | 315.22M | 294.82M | 322.72M | 293.1M | 298.09M | 281.43M | 304.52M | 363.28M | 316.21M | 263.58M | 278.43M | 298.74M | 275.34M | 250.81M | 268.53M | 336.3M | 264.09M | 266.53M | 265.42M | 400.02M | 382.31M | 391.78M | 412.48M | 406.89M | 386.89M | 386.43M | 408.88M | 353.49M | 352.02M | 341.8M |
| Selling, General, and Administrative Revenue Growth | -9.75% | +5.32% | +6.98% | +1.48% | -9.71% | +6.52% | +3.53% | +9.77% | -12.67% | +3.90% | +15.93% | +6.92% | -8.65% | +10.11% | -1.68% | +5.92% | -7.58% | -16.18% | +14.89% | +19.97% | -5.33% | -6.80% | +8.50% | +9.78% | -6.60% | -20.15% | +27.34% | -0.91% | +0.42% | -33.65% | +4.63% | -2.42% | -5.02% | +1.37% | +5.17% | +0.12% | -5.49% | +15.67% | +0.42% | +2.99% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |